Clinical trial
Resting Full-cycle Ratio-guided Step by Step Dilation for Drug-coated Balloon Treatment of de Novo Coronary Lesions (REDUCE) Study
NCT05107024 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Resting Full-cycle Ratio-guided Step by Step Dilation for Drug-coated Balloon Treatment of de Novo Coronary Lesions (REDUCE) Study
- Lead sponsor
- Shenzhen People's Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 1, 2021
- Completion date
- December 1, 2023
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
de novo coronary lesions